An entity of Swedish private equity firm EQT has agreed to acquire Qiagen for €10.8 billion (about $12.1 billion) cash, both ...

The University of Washington School of Medicine Institute for Protein Design (IPD) has partnered with Nvidia to develop an ...

The partnership is now expanding into a joint drug-target discovery effort that leverages proprietary causal biological data from PerturbAI.

ASHG President Susan Slaugenhaupt, PhD, opened the society’s Montreal meeting with a heartfelt address of hope, leadership, ...

In this GEN webinar, our expert speaker Josh Wheeler, MD, PhD, will discuss a biology-first, interpretable AI approach to ...

Gene therapy firms need to consider patients when choosing a viral vector production method, say researchers behind new economic analysis.

Pluristyx leaders outline how better starting materials, automation, and process control can scale iPSC manufacturing.

Catalytic reactive-hydrogen membranes capture and break down six PFAS in water, achieving up to 96% removal and 83% ...

Roche and Hansoh Pharmaceutical Group have launched their second collaboration focused on developing cancer-fighting antibody ...

The companies plan to first optimize Takara's SMART-seq RNA-seq library prep workflows on SPT Labtech's firefly liquid ...

PacBio and Verily Health will integrate HiFi long-read sequencing with health data and cloud tools to support biomedical ...

IMU Biosciences and UK Biobank will profile 80,000 blood samples using technologies from Waters and Ultima Genomics.